Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning - PubMed (original) (raw)
. 2004 Oct 15;104(8):2254-62.
doi: 10.1182/blood-2004-04-1506. Epub 2004 Jun 29.
Jennifer E Baker, Rainer Storb, Theodore A Gooley, Brenda M Sandmaier, Michael B Maris, David G Maloney, Shelly Heimfeld, Dmitrij Oparin, Eustacia Zellmer, Jerald P Radich, F Carl Grumet, Karl G Blume, Thomas R Chauncey, Marie-Térèse Little
Affiliations
- PMID: 15226174
- DOI: 10.1182/blood-2004-04-1506
Free article
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
Frédéric Baron et al. Blood. 2004.
Free article
Abstract
We analyzed the kinetics of donor engraftment among various peripheral blood cell subpopulations and their relationship to outcomes among 120 patients with hematologic malignancies given hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning consisting of 2 Gy total body irradiation (TBI) with or without added fludarabine. While patients rapidly developed high degrees of donor engraftment, most remained mixed donor/host chimeras for up to 180 days after HCT. Patients given preceding chemotherapies and those given granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell (G-PBMC) grafts had the highest degrees of donor chimerism. Low donor T-cell (P = .003) and natural killer (NK) cell (P = .004) chimerism levels on day 14 were associated with increased probabilities of graft rejection. High T-cell chimerism on day 28 was associated with an increased probability of acute graft-versus-host disease (GVHD) (P = .02). Of 93 patients with measurable malignant disease at transplantation, 41 achieved complete remissions a median of 199 days after HCT; 19 of the 41 were mixed T-cell chimeras when complete remissions were achieved. Earlier establishment of donor NK-cell chimerism was associated with improved progression-free survival (P = .02). Measuring the levels of peripheral blood cell subset donor chimerisms provided useful information on HCT outcomes and might allow early therapeutic interventions to prevent graft rejection or disease progression.
Similar articles
- High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Baron F, Maris MB, Storer BE, Sandmaier BM, Panse JP, Chauncey TR, Sorror M, Little MT, Maloney DG, Storb R, Heimfeld S. Baron F, et al. Leukemia. 2005 May;19(5):822-8. doi: 10.1038/sj.leu.2403718. Leukemia. 2005. PMID: 15772701 - Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
Grosskreutz C, Ross V, Scigliano E, Fruchtman S, Isola L. Grosskreutz C, et al. Biol Blood Marrow Transplant. 2003 Jul;9(7):453-9. doi: 10.1016/s1083-8791(03)00139-3. Biol Blood Marrow Transplant. 2003. PMID: 12869959 Clinical Trial. - Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.
Nakamae H, Storer BE, Storb R, Storek J, Chauncey TR, Pulsipher MA, Petersen FB, Wade JC, Maris MB, Bruno B, Panse J, Petersdorf E, Woolfrey A, Maloney DG, Sandmaier BM. Nakamae H, et al. Biol Blood Marrow Transplant. 2010 Mar;16(3):384-94. doi: 10.1016/j.bbmt.2009.11.004. Epub 2009 Nov 10. Biol Blood Marrow Transplant. 2010. PMID: 19900571 Free PMC article. Clinical Trial. - Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S. Strober S. Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. doi: 10.1016/j.bcmd.2007.06.019. Epub 2007 Sep 10. Blood Cells Mol Dis. 2008. PMID: 17827036 Review.
Cited by
- Neutrophil antigen antibodies affect engraftment and secondary graft failure in hematopoietic progenitor cell transplantation.
Alswied A, Hassan S, Rai H, Flegel WA. Alswied A, et al. Transfusion. 2024 Jun;64(6):1050-1058. doi: 10.1111/trf.17830. Epub 2024 Apr 18. Transfusion. 2024. PMID: 38634344 - Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS.
Loke J, McCarthy N, Jackson A, Siddique S, Hodgkinson A, Mason J, Crawley C, Gilleece M, Peniket A, Protheroe R, Salim R, Tholouli E, Wilson K, Andrew G, Dillon R, Khan N, Potter V, Krishnamurthy P, Craddock C, Freeman S. Loke J, et al. Blood Adv. 2023 Jul 25;7(14):3666-3676. doi: 10.1182/bloodadvances.2022009493. Blood Adv. 2023. PMID: 37058448 Free PMC article. - Chimerism analysis for clinicians: a review of the literature and worldwide practices.
Blouin AG, Askar M. Blouin AG, et al. Bone Marrow Transplant. 2022 Mar;57(3):347-359. doi: 10.1038/s41409-022-01579-9. Epub 2022 Jan 26. Bone Marrow Transplant. 2022. PMID: 35082369 Free PMC article. Review. - A practical guide to chimerism analysis: Review of the literature and testing practices worldwide.
Blouin AG, Ye F, Williams J, Askar M. Blouin AG, et al. Hum Immunol. 2021 Nov;82(11):838-849. doi: 10.1016/j.humimm.2021.07.013. Epub 2021 Aug 14. Hum Immunol. 2021. PMID: 34404545 Free PMC article. Review. - A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is Key.
Ferdjallah A, Young JH, MacMillan ML. Ferdjallah A, et al. Front Pediatr. 2021 Jul 27;9:634449. doi: 10.3389/fped.2021.634449. eCollection 2021. Front Pediatr. 2021. PMID: 34386464 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- CA18029/CA/NCI NIH HHS/United States
- HL36444/HL/NHLBI NIH HHS/United States
- CA78902/CA/NCI NIH HHS/United States
- CA92058/CA/NCI NIH HHS/United States
- CA49605/CA/NCI NIH HHS/United States
- CA15704/CA/NCI NIH HHS/United States
- P01 CA078902/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources